What is an MDCG guidance document?

MDCG (Medical Device Coordination Group) guidance documents are non-binding technical guidance published by the European Commission to assist manufacturers, Notified Bodies, and competent authorities in implementing EU MDR 2017/745 and EU IVDR 2017/746. They cover clinical evaluation, post-market surveillance, UDI, EUDAMED, and other compliance topics.

What FDA guidance documents are required for a 510(k) submission?

FDA 510(k) submissions must follow applicable FDA guidance documents including the general 510(k) Guidance, device-specific guidances, and quality system regulation (21 CFR Part 820). Key documents include guidance on substantial equivalence determinations, cybersecurity pre-market requirements, and device-type-specific performance standards.

What is a Team NB document?

Team NB (Team of Notified Bodies) publishes position papers, recommendations, and guidance documents developed collaboratively by European Notified Bodies designated under EU MDR and IVDR. These documents clarify application of regulatory requirements and support harmonised conformity assessment practices across Notified Bodies.

What clinical guidelines are available on Medical Device Navigator?

Medical Device Navigator provides access to 700+ clinical guidelines and recommendations from major European and American medical societies including ESC, ESMO, EULAR, AHA/ACC, ASCO, ADA, NICE, and many more. Guidelines are organized by specialty and geographic scope (European vs American) to help medical device professionals understand clinical practice standards relevant to their devices.

MDCG Guidance Archives

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

MDCG Guidance

MDCG 2025-4: Guidance on safe making available of MDSW apps on online platforms

MDCG 2023-4: MDSW – Hardware combinations guidance

MDCG 2025-6: FAQ on Interplay between MDR/IVDR and the Artificial Intelligence Act

MDCG 2019-9: Summary of safety and clinical performance

MDCG 2025-9: Guidance on Breakthrough Devices (BtX) under Regulations 2017/745 & 2017/746

MDCG 2020-6: Guidance on sufficient clinical evidence for legacy devices

MDCG 2020-5: Guidance on clinical evaluation – Equivalence

MDCG 2020-8: Guidance on PMCF evaluation report template

MDCG 2020-7: Guidance on PMCF plan template

MDCG 2020-13: Clinical evaluation assessment report template

MDCG 2020-10/1: Guidance on safety reporting in clinical investigations

MDCG 2021-8: Clinical investigation application/notification documents

MDCG 2021-6: Q&A regarding clinical investigation under Regulation 2017/745

MDCG 2021-20: Instructions for generating CIV-ID for MDR Clinical Investigations

MDCG 2021-28: Substantial modification of clinical investigation under MDR

MDCG 2023-7: Guidance on exemptions from clinical investigations per Article 61(4)-(6) MDR

MDCG 2024-5: Guidance on the Investigator’s Brochure content

MDCG 2024-3: Guidance on content of the Clinical Investigation Plan

MDCG 2024-15: Guidance on publication of clinical investigation reports in absence of EUDAMED

MDCG 2024-10: Clinical evaluation of orphan medical devices

MDCG 2019-15: Guidance notes for manufacturers of class I medical devices

MDCG 2025-5: Q&A regarding performance studies of IVDs under Regulation 2017/746

Helsinki Procedure: Helsinki Procedure for borderline and classification under MDR & IVDR

MDCG 2022-5: Guidance on borderline between medical devices and medicinal products under MDR

Medical Device Navigator

Directory

Company

Content